Pure Biologics is a company that specializes in the technology of in vitro selection of antibodies and aptamers. It focuses on the production and analytics of recombinant proteins and their interactions. In addition, the company develops state-of-the-art technological platforms for the generation of antibody fragments (PureSelect and PureSelect2 platforms), as well as for the selection of chemically modified aptamers (PureApta).